Niagen Bioscience Inc
NAGE | NASDAQ
$3.04
+$0.05 (+1.67%)
At close: Sep 21, 2026, 4:00 PM ET
$3.09
+$0.05 (+1.63%)
Pre-market:
Sep 22, 2026, 7:04 AM ET
Market Data
Market Cap $242.12M
Enterprise Value $177.71M
Beta 2.09
Average Volume 770.4K
Shares Outstanding (Diluted) 82.5M
Shares Change YoY -4.33%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US1710774076
Price Performance
Price Change 1M -5.0%
Price Change 3M -10.1%
Price Change 6M -32.7%
Price Change YTD -51.4%
Price Change 1Y -70.3%
Price Change 3Y 121.9%
Price Change 5Y -52.9%
1M CAGR (ann.) -2.6%
1Y CAGR (ann.) -70.0%
5Y CAGR (ann.) -16.1%
All-Time CAGR -7.1%
Valuation
PE Ratio 16.00
Forward PE 17.66
PEG Ratio -0.90
Forward PEG 2.10
PS Ratio 1.88
Forward PS 1.60
PB Ratio 2.93
P/FCF Ratio 42.67
P/Adj. FCF Ratio -190.79
P/OCF Ratio 43.43
EV/Sales 1.38
EV/EBIT 10.67
EV/EBITDA 9.62
EV/FCF 31.32
Earnings Yield 6.3%
FCF Yield 2.3%
Adj. FCF Yield -0.5%
Financial Health
Net Cash $66.74M
Total Debt $2.33M
Cash & Short-Term Investments $66.74M
Total Assets $106.59M
Current Ratio 6.50
Quick Ratio 5.13
Debt / Equity Ratio 0.03
Debt / EBITDA 0.13
Debt / FCF 0.41
OCF / Debt 2.55
Interest Coverage 0.00
Altman Z-Score 6.63
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 64.2%
Operating Profit Margin 6.7%
EBITDA Margin 14.3%
Net Profit Margin 12.4%
FCF Margin 4.4%
Adj. FCF Margin -1.0%
SBC / Revenue 5.4%
SBC Impact (per share) -122.4%
Returns
Return on Assets 15.0%
Return on Equity 20.5%
Return on Invested Capital 8.8%
Return on Capital Employed 9.4%
Return on Tangible Assets 15.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 16.8%
Revenue CAGR 5Y 15.8%
Revenue CAGR 10Y 17.0%
EPS CAGR 3Y 81.7%
EPS CAGR 5Y 644.7%
EPS CAGR 10Y 33.6%
FCF CAGR 3Y 50.1%
FCF CAGR 5Y 522.2%
FCF CAGR 10Y 45.5%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y 19.4%
Revenue Growth Next 3Y 17.6%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) $0.01
EPS Growth Est (next Q) -80.0%
Revenue Est (next Q) $34.45M
Revenue Growth Est (next Q) 1.4%
Fair Value Estimates
Graham Number $2.11
Graham Upside -30.6%
Lynch Fair Value $4.75
Lynch Upside 56.3%
Price Target $10.33
Price Target Upside 239.8%
Cash Flow
Operating Cash Flow $5.95M
Free Cash Flow $5.67M
Adj. Free Cash Flow $-1.27M
FCF Per Share $0.07
OCF Per Share $0.07
OCF/S Ratio 4.6%
Income Statement
Revenue $129.08M
Gross Profit $82.92M
Operating Income $8.62M
EBITDA $18.48M
Net Income $15.99M
EPS (Diluted) $0.19
Revenue / Employee $1.1M
Profit / Employee $136.68K
Employees 117
Add to Watchlist
Select watchlists to add or remove NAGE